Neuroendocrine tumour (NET), Secondary cancers
Results
Phase 2
This trial compared 2 types of chemotherapy for people with a neuroendocrine carcinoma (NEC).
It was for people who had a NEC that didn’t start in the lungs and it:
was fast growing (grade 3)
couldn’t be removed with surgery or it had spread elsewhere in the body
The trial was open for people to join between 2018 and 2021. The team published the results in 2023.
Recruitment start: 16 November 2018
Recruitment end: 21 December 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mairéad G McNamara
Leeds Institute of Clinical Trials Research
NIHR Clinical Research Network
Servier UK
The Christie NHS Foundation Trust
Last reviewed: 11 March 2024
CRUK internal database number: 17162
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
